Lung Cancer Update

Featuring perspectives from Dr Jonathan Goldman and Dr Zofia Piotrowska, including the following topics:
Introduction (0:00)
Current Management of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Dr Goldman (0:38)
Nonmetastatic EGFR-Mutated NSCLC, Exon 20 Insertion Mutations and Novel Agents — Dr Piotrowska (33:20)

CME information and select publications

Featuring an interview with Prof Martin Reck, including the following topics:
Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunotherapy and maintenance lurbinectedin/atezolizumab (0:00)
Biology of small cell lung cancer and pharmacodynamics of systemic treatment (3:25)
Considerations with maintenance therapy for ES-SCLC (9:31)
Considerations with immunotherapy for ES-SCLC (13:12)
Curability of SCLC with systemic therapy (15:17)
Data with chemoimmunotherapy for patients with poor performance status (25:55)
Future developments in therapy for SCLC (30:11)
Rapid fire: Small Cell 101 (35:45)

CME information and select publications

Dr Christine L Hann from the Johns Hopkins University School of Medicine in Baltimore, Maryland, and Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the management of SCLC.
CME information and select publications

Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported over the past year.
CME information and select publications here.

Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer.
CME information and select publications here.